The makers of remdesivir, touted as a treatment for COVID-19, are pushing back on a study by the World Health Organization that concluded the medication has little or no effect on patients' recovery times or mortality rates.
The results come from the WHO's"Solidarity" trial, which used over 11,000 adult patients across more than 30 countries. It evaluated four potential drugs, including remdesivir. Gilead told Reuters"We are concerned the data from this open-label global trial has not undergone the rigorous review required to allow for constructive scientific discussion,”
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »